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Abstract 
Pleomorphic  adenomas  (benign  mixed
tumors) are the most common tumors of glan-
dular origin in the head and neck and are one
of the few benign neoplasms that can undergo
malignant transformation.
1 Mixed tumors that
are seemingly benign at the microscopic level
but metastasize have been termed metastasiz-
ing  mixed  tumors  (MZMTs).  The  entity  of
metastasizing benign mixed tumors has been
reported  since  the  early  1940s,  with  up  to
approximately 50 cases described in the liter-
ature to date. Despite their bland morphologic
appearance,  MZMTs  have  been  associated
with an overall mortality rate of about 20-40%.
We report the case of a MZMT of the kidney
almost  30  years  after  lateral  parotidectomy
owing to the same tumor entity. For benign
mixed tumors, we are unaware of more than
two other cases of metastasis to the kidney
that have been published, whereas metastases
to the bone, lung, and lymph nodes are more
common. Parotidectomy is widely accepted as
the first choice of treatment,
13 but once metas-
tases have occurred the therapeutic strategy
is uncertain with surgery being the only cura-
tive option in cases with resectable disease.
This case report provides information about
the rare event of metastatic disease to the kid-
ney  and  points  out  therapeutic  strategies.
However, in view of the general lack of ade-
quate information in the literature, the best
therapy  for  systemic  disease  still  remains
unresolved. 
Case Report
A  49-year-old  woman  suffered  from  a  car
accident and was brought to our clinic. A rou-
tine ultrasound scan of the abdomen in the
emergency unit detected a kidney tumor on
the right side. The patient did not report any
symptoms that would point to a disease of the
urogenital  tract.  The  physical  examination
was without pathological findings. A comput-
erized tomography (CT) scan of the abdomen
revealed the presence of two suspect cortical
tumors (20 mm and 50 mm in diameter) in
the right kidney. In addition, the CT scan was
suspicious for pulmonary metastases and a CT
scan of the chest confirmed the presence of
multiple pulmonary lesions in both lungs, with
a  maximal  diameter  of  11  mm  in  the  right
lower lobe. The right kidney was removed by
laparoscopic radical nephrectomy as clinically
renal cell carcinoma was suspected, without
complications. 
Pathological Findings
Gross findings
On sectioning the cut surface of the kidney
revealed a white, solid, lobulated, well-circum-
scribed  tumor  in  the  middle  third  of  the
parenchyma, which measured 55x55x50 mm
and  penetrated  the  capsule  (Figure  1A).
Another smaller, similar focus of 10 mm in
diameter  was  found  in  the  surrounding
parenchyma close to the hilus. 
Histological findings
The  microscopic  features  of  both  tumors
showed a mixed cell composition with mes-
enchymal elements demonstrating chondroid
differentiation embedded in a myxoid matrix,
as well as epithelial components consisting of
ductal structures without atypia (Figure 1B).
Immunohistochemical  studies  showed  that
the epithelial component stained positive for
pan-cytokeratin AE1/AE3 with partial expres-
sion  of  the  myoepithelial  markers  p63
(Figure 1C) and a very low Ki-67 proliferation
rate (Figure 1D).
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Figure 1. (A) Gross appear-
ance  of  the  dissected
nephrectomy  specimen
showing  a  well-defined
tumor  with  a  homoge-
neous tan cut surface. (B)
Histology displays the typ-
ical  features  of  a  benign
(metastasizing)  pleomor-
phic adenoma in the right
kidney  with  a  mesenchy-
mal  cartilaginous  compo-
nent and an epithelial duc-
tal component within renal
tissue  (left  lower  corner).
(C) The myoepithelial cells
showing expression of p63.
(D) The Ki-67+ prolifera-
tive  index  is  seen  as
extremely  low  (<1%).  (E)
Macroscopy of the paraffin
block from 1978 showing
a small nodular tumor of
the  parotid  gland  with  a
white-to-tan  cut  surface.
(F) The identical morphol-
ogy of a pleomorphic ade-
noma in the salivary gland
tissue is demonstrated (left
lower corner).[page 168] [Rare Tumors 2009; 1:e54]
Statement of the pathologist
The histopathological features of the tumors
disclosed a mixed tumor of salivary gland ori-
gin, in particular for a metastasizing pleomor-
phic adenoma, but were not typical of a pri-
mary tumor of the kidney. 
The past history of the patient revealed that
a  lateral  parotidectomy  on  the  left  side  had
been performed 29 years previously because of
a tumor mass of the parotid gland diagnosed as
a  pleomorphic  adenoma.  The  pathological
report described a 45x35x28 mm gland with a
tumor 22 mm in diameter. It was possible to
retrieve  the  old  paraffin  blocks  from  the
archives of the Institute of Pathology of the
Charité–Campus  Benjamin  Franklin,  which
showed  a  white  cut  surface  of  the  tumor
(Figure 1E). On histology, even in retrospect,
no signs of malignancy were detected and the
tumor was still classified as a pleomorphic ade-
noma with characteristic epithelial and mes-
enchymal composition (Figure 1F) and great
morphological similarity to the kidney metas-
tasis 29 years later. 
Discussion
We  report  the  case  of  a  metastasizing
“benign” pleomorphic adenoma of the kidney
almost 30 years after a lateral parotidectomy
owing  to  the  same  tumor  entity.  A  CT  scan
revealed  suspect  pulmonary  masses  in  both
lungs that have remained stable over a period
of  three  months.  After  discussion  with  an
oncologist  a  surveillance  strategy  of  the
asymptomatic patient was agreed. 
Mixed tumors of the salivary glands general-
ly are divided into benign mixed tumors and
malignant mixed tumors, represented by carci-
nosarcomas  (true  malignant  mixed  tumors)
and  so-called  carcinoma  ex-mixed  tumors,
which  can  develop  within  a  benign  mixed
tumor over an extended period of time.
1 Rarely
will a mixed tumor that is seemingly benign at
the  microscopic  level  metastasize.  These
tumors have been termed metastasizing mixed
tumors (MZMTs) and have been classified as
metastasizing  pleomorphic  adenomas  within
the category of malignant epithelial tumors of
the salivary gland by the WHO. Some authors
suggest that a MZMT could be the intermediate
link  in  the  transformation  of  a  pleomorphic
adenoma into a carcinoma ex-mixed tumor.
2-5 A
published case report from Czader et al. under-
lined the suggestion that MZMT and carcinoma
ex-mixed  tumor  could  represent  different
stages along a common biological pathway.
2
Histopathological and clinical criteria to dif-
ferentiate metastatic mixed tumors from non-
metastatic  mixed  tumors  are  lacking.  There
are no predictive factors available to determine
which mixed tumor may have the potential to
metastasize  and  which  patient  may  die  of
metastatic disease.
6 However, the probability
that a benign mixed tumor will become malig-
nant depends on the period of time it has been
allowed to develop without treatment. The risk
of malignant transformation – usually into a
carcinoma  ex-pleomorphic  tumor  –  ranges
from 1.5% in the first five years to 9.5% after
15 years.
7 It is estimated that approximately
20-40% of patients with MZMT will die from
the  disease  eventually.
6 Surgical  manipula-
tions are thought to create a metastatic poten-
tial but do not truly explain the occurrence of
metastases.
8 Metastases were discovered from
6  to  52  years  after  the  primary  tumor  was
removed.
9 About 40-50% of patients suffering
from  carcinoma  ex-pleomorphic  adenoma
develop local recurrence and up to 70% develop
local or distant metastases.
10 Systematic data
for  MZMTs  concerning  recurrence  and
metastatic rates are lacking. In contrast to our
case, the patients normally have at least one
episode  of  tumor  recurrence  at  the  primary
site  before  the  development  of  metastases,
which may occur many years after the presen-
tation  of  the  primary  mixed  tumor.  The
metastatic potential of mixed tumors is related
to the accumulation of key genetic alterations.
The  development  of  a  carcinoma  ex-mixed
tumor apparently could be, in part, the conse-
quence of the accumulative loss of chromoso-
mal loci at 3p, 9p, and 17p.
11 A number of case
reports describe the simultaneous appearance
of benign and malignant components of mixed
tumors in the same tumor manifestation.
2,5,12
The order of genetic alterations along tumor
progression seems to be variable and may dif-
fer for each salivary tumor, but for MZMT no
recurrent  genetic  defect  has  been  reported.
Parotidectomy is widely accepted as the first
choice  of  treatment,
13 but  once  metastases
have  occurred,  the  therapeutic  strategy  is
uncertain with surgery being the only curative
option in cases with resectable disease. 
Conclusions
Metastatic  pleomorphic  adenoma  of  the
salivary gland to the kidney is a very rare neo-
plasm, which requires a careful patient histo-
ry and knowledge of the lesion for patholo-
gists and clinicians to reach the correct diag-
nosis. There is no approved hypothesis as to
how  a  morphologically  benign  tumor  may
metastasize.  Surgery  of  resectable  disease
with  curative  intent  should  be  attempted
whenever possible. In view of the general lack
of adequate information in the literature, the
best  therapy  for  systemic  disease  still
remains unresolved.
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